HELP
Cybin Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · CA
$12.22
+3.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 102.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.69x
- Price / sales
- —
- Price / cash flow
- -5.84x
Enterprise value
- Enterprise value
- $726.6M
- EV / sales
- —
- EV / EBITDA
- -4.10x
- EV / EBIT
- -4.10x
- Market cap
- $892.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026